In a study of 232 people taking medication for psoriasis, those who also took statins had fewer of the thick, red, scaly, itchy patches that are the hallmark sign of psoriasis, compared with people who didn't take the cholesterol-lowering drugs.
"There was a trend toward less severe psoriasis severity in people taking statins," says researcher Adam Perry, a fourth-year medical student at Emory University in Atlanta.
The study is preliminary and doesn't prove cause and effect. And no one should start taking statins in an attempt to ward off psoriasis symptoms, doctors stress.
But the findings, presented at the American Academy of Dermatology annual meeting, raise an interesting possibility worthy of further study, experts agree.
About 7.5 million Americans suffer from psoriasis, a lifelong (chronic) disorder characterized by inflammation of skin and, often, the joints.
Statins have been shown to reduce inflammation in the body in animal and lab studies.
To date, there has only been one small study of seven patients looking at the link between statins and psoriasis, Perry says. In that study, there was about a 50% reduction in symptom severity after eight weeks of statin therapy.
The new study involved 232 people with psoriasis, 66 of whom were taking statins for high cholesterol.
After starting a new medication for their psoriasis, there was a 64% reduction in the percentage of the body covered with the psoriasis lesions in people on statins. In contrast, there was only a 45% reduction in people not taking statins.
Statistical analysis showed the finding could have been due to chance. But Perry and experts like Alan Menter, MD, who was not involved with the study, agree that's probably because too few people were studied.
"There's a general air of excitement about the possibility [that statins could improve psoriasis symptoms]. Given that statins fight the inflammation [that fuels psoriasis], we would like to follow up," says Menter, chair of the psoriasis research unit at Baylor Research Institute in Dallas.